Only One Blood Type Link to Disease Confirmed in Large Scale Review

For decades, blood type has been quietly woven into medical folklore. Some believe it shapes everything from infection risk to chronic disease. Others dismiss it as coincidence dressed up as biology.

Now, one of the most comprehensive analyses ever conducted has attempted to settle the debate.

Drawing from dozens of systematic reviews and hundreds of associations, researchers have taken a step back to ask a simple but critical question: Which links between blood type and disease actually hold up under scrutiny?

The answer is more restrained than many might expect.

Out of 270 reported associations between blood groups and health outcomes, only one meets the highest standard of evidence. Many others show signals, but those signals are often inconsistent, weak, or potentially biased.

What emerges is not a sweeping confirmation of blood type as a major determinant of health, but a more nuanced picture. Blood type may matter in certain contexts, yet its influence is far from universal.

What Scientists Set Out to Test

The research team conducted what is known as an umbrella review, a method designed to evaluate existing meta-analyses rather than individual studies.

This approach allows scientists to compare large bodies of evidence at once, while also testing how reliable those findings are.

Instead of asking whether a single study shows a link, they ask:

• Does the association appear consistently across many studies?
• Is the effect large enough to matter?
• Could bias or random variation explain the result?

The review included 51 meta-analyses, covering 270 unique associations between blood groups and diseases. These ranged across cancer, infections, cardiovascular conditions, metabolic disorders, and more.

Each association was graded based on strength of evidence, from weak to convincing.

One Finding Stands Above the Rest

Among all the data examined, only one association reached what researchers classify as “convincing” evidence.

People with blood group B showed a higher risk of developing type 2 diabetes compared to those without this blood type.

The increase in risk was modest, about 28 percent higher odds. Yet what makes this finding stand out is not the size of the effect, but its consistency.

Unlike most other associations, this link:

• Was supported by a large number of cases
• Showed low variability between studies
• Remained stable when tested for statistical bias
• Held up under multiple analytical checks

In other words, it passed the strictest filters scientists use to separate signal from noise.

Even so, the researchers emphasize caution. The evidence is strong, but not definitive proof of causation.

Many Other Links Show Signals, But Not Certainty

Beyond type 2 diabetes, the analysis identified several associations that appear suggestive or highly suggestive, but fall short of firm conclusions.

Cancer Patterns

Certain blood types showed links to specific cancers:

• Blood group A was associated with a higher risk of gastric and pancreatic cancers
• Blood group B showed a possible increase in esophageal cancer risk
• Blood group O appeared to have a lower risk for some cancers

These patterns have been reported before, but the review highlights an important limitation. Many of these findings vary depending on study design, population, and statistical methods.

As a result, they remain plausible, but not definitive.

Infectious Diseases

Blood type has long been suspected to influence susceptibility to infections.

The review found:

• Blood group A and B linked to higher risk of COVID-19 infection
• Blood group O linked to a lower risk of COVID-19
• Multiple blood groups associated with HIV infection in some analyses

There were also signals linking blood type to malaria infection risk.

Yet here again, consistency is an issue. While some associations appear strong, others conflict across studies or show signs of bias.

Cardiovascular Conditions

Several associations emerged in cardiovascular health:

• Blood group A and non-O types linked to higher risk of venous thromboembolism
• Blood group A associated with increased risk of heart attack
• Blood group O linked to a higher risk of bleeding complications

These findings align with earlier research suggesting that blood type may influence clotting mechanisms.

Still, most of these associations were rated as “suggestive” rather than definitive.

Why Blood Type Might Influence Disease

At first glance, it may seem surprising that blood type could affect conditions as diverse as diabetes, infections, and cancer.

But biologically, there are several plausible explanations.

Blood groups are determined by molecules, known as antigens, that sit on the surface of red blood cells and other tissues. These molecules are not just passive markers. They interact with the immune system and influence how the body responds to threats.

Research suggests that blood type may affect:

• Levels of inflammatory proteins
• Immune system signaling
• The composition of gut microbiota
• Clotting factors in the bloodstream

For example, certain blood types are associated with higher levels of proteins involved in inflammation, which is a known contributor to metabolic diseases like diabetes.

In cardiovascular disease, differences in clotting proteins such as von Willebrand factor may explain why some blood types are linked to higher clotting risk.

In infections, blood group antigens can influence how pathogens attach to cells or evade immune responses.

Why Most Evidence Remains Uncertain

Despite these biological clues, the majority of associations did not reach high levels of confidence.

There are several reasons for this.

1. Observational Limitations

Most studies included in the review were observational. This means they can identify correlations, but cannot prove cause and effect.

Other hidden factors, such as lifestyle or genetics, may explain the observed links.

2. Study Variability

Different studies often used different comparison groups. For example, one study might compare blood group A to O, while another compares A to all other types.

This makes results difficult to align.

3. Statistical Noise

When hundreds of associations are tested, some will appear significant purely by chance.

The review found that many associations weakened or disappeared when tested for bias.

4. Limited Certainty

Even among statistically significant findings, many were rated as low or very low certainty using established grading systems.

This means the true effect could differ substantially from the reported one.

Why This Matters

Understanding whether blood type influences disease risk has practical implications.

If certain blood groups truly carry higher risk for specific conditions, they could help guide:

• Early screening strategies
• Preventive interventions
• Personalized risk assessment

However, this review suggests that such applications remain limited for now.

The strongest evidence supports only one association, and even that requires further confirmation.

For most conditions, blood type alone is unlikely to be a major driver of risk compared to factors like diet, environment, and genetics.

A Field Still Searching for Clarity

The idea that blood type shapes health is not new. It has persisted for decades, fueled by scattered findings and public fascination.

What this large-scale analysis provides is perspective.

It shows that while some signals exist, most do not yet meet the standards required for confident conclusions.

The relationship between blood type and disease is real in some cases, but far from universal.

Future research, particularly large, well-designed prospective studies, will be needed to clarify which associations are genuine and which are artifacts of incomplete data.

Until then, blood type remains an intriguing piece of the puzzle, but not the defining factor in human health.

The research was published in BMC Medicine on May 20, 2024.